WOSCI Author Services

今天，我们来看看这本SCI期刊：JOURNAL OF MOLECULAR ENDOCRINOLOGY。从现有的记录来看，JOURNAL OF MOLECULAR ENDOCRINOLOGY 的2021年影响因子(JCR2020)是5.098，2020年是3.562，比2020年增长1.536，增长比例43.12%。

关于此刊的具体情况，大家可以看看：

JOURNAL OF MOLECULAR ENDOCRINOLOGY 的收稿范围，期刊是如此介绍的(截取部分内容)，详情请阅读：

https://jme.bioscientifica.com/page/scope

Journal of Molecular Endocrinology is a leading global journal that publishes original research articles and reviews. The journal focuses on molecular and cellular mechanisms in endocrinology, including: gene regulation, cell biology, signalling, mutations, transgenics, hormone-dependant cancers, nuclear receptors. Basic and pathophysiological studies at the molecule and cell level are considered, as well as human sample studies where this is the experimental model of choice. Technique studies including Omics, CRISPR or gene editing are also encouraged, provided they are set within a larger endocrinology context.

期刊接受时间

• Received 12 October 2020, Accepted 29 October 2020

• Received 17 December 2020, Accepted 22 January 2021

• Received 16 September 2020, Accepted 27 October 2020

• Received 14 December 2020, Accepted 5 January 2021

• Received1 October 2020, Accepted 20 October 2020

• Received 21 October 2020, Accepted 26 November 2020

• Received 26 November 2020, Accepted 5 January 2021

• Received 28 October 2020, Accepted 2 December 2020

期刊年发文量

对于 JOURNAL OF MOLECULAR ENDOCRINOLOGY 的发文量，2018年发文90多篇，2019年发文60多篇，2020年发文50多篇，2021年发文40多篇。

影响因子

即时影响因子计算发现，2022年3月2日，4.631分。按照常规期刊计算方法，以及往年经验，在2022年6月份公布的IF中，它或许在5分右！期待6月份新IF的公布！

此图为“51选刊”绘制

如果还没有注册过账户，只需点击“Create an Account”注册账户即可！

有5+分以上发表要求的，来看看这个潜力股的SCI期刊吧！

版权声明：本文转自“51选刊”，文章转载只为学术传播，不代表本号观点，无商业用途，版权归原作者所有，如涉及侵权问题，请联系我们，我们将及时修改或删除。